NOVEL QUINAZOLINE COMPOUND AS KRAS INHIBITOR

The present invention relates to a novel quinazoline compound as a KRAS inhibitor and, more specifically, to a novel quinazoline compound useful as a KRAS protein inhibitor, an isomer, and a pharmaceutical composition for cancer treatment comprising same. La présente invention concerne un nouveau co...

Full description

Saved in:
Bibliographic Details
Main Authors PARK, Jong Seon, HONG, Soo Jung, LEE, Jung Woo, KIM, Jin Woong, HONG, Sung Jun, PARK, Joon Tae, HONG, Chang Hee, LEE, Jin Hee, LEE, Joo Yun, AN, Kyung Mi, SONG, Haeng Jin, YOON, Hong Chul
Format Patent
LanguageEnglish
French
Korean
Published 28.03.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a novel quinazoline compound as a KRAS inhibitor and, more specifically, to a novel quinazoline compound useful as a KRAS protein inhibitor, an isomer, and a pharmaceutical composition for cancer treatment comprising same. La présente invention concerne un nouveau composé de quinazoline en tant qu'inhibiteur de KRAS et, plus spécifiquement, un nouveau composé de quinazoline utile en tant qu'inhibiteur de protéine KRAS, un isomère, et une composition pharmaceutique pour le traitement du cancer le comprenant. 본 발명은 KRAS 저해 물질로서 신규한 퀴나졸린 화합물에 관한 것으로, 보다 구체적으로는 KRAS 단백질 저해제로서 유용한 신규한 퀴나졸린 화합물, 이성질체, 및 이를 포함하는 암 치료를 위한 약학적 조성물에 관한 것이다.
Bibliography:Application Number: WO2023KR14439